跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SMOFKABIVEN PERIPHERAL - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
SMOFKABIVEN PERIPHERAL
Authorized
STANDARD
SMOFKABIVEN PERIPHERAL
fresenius kabi canada ltd
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
7d26e7e64657e362
Company
fresenius kabi canada ltd
Type
Standard
Approval Details
Approval Id
7d26e7e64657e362
Drug Approval Canada Name
SMOFKABIVEN PERIPHERAL
Product Name
SMOFKABIVEN PERIPHERAL
Status
Marketed
Status Date
2017-02-14
Original Market Date
2017-02-14
Din
02456206
Drug Class
Human
Dosage Form
Emulsion
Route Of Administration
Intravenous
Schedule
Ethical
Ahfs
40:12.00
Atc Original
B05BA10 COMBINATIONS
Atc Name
b 05 ba 10
Aig Number
2758251001
Company Name
fresenius kabi canada ltd
Company Address
165 Galaxy Blvd, Suite 100, Toronto, Ontario, Canada, M9W 0C8
Active Ingredients
ALANINE
440 MG / 100 ML
ARGININE
380 MG / 100 ML
DEXTROSE
7.1 G / 100 ML
ISOLEUCINE
160 MG / 100 ML
CALCIUM CHLORIDE
18 MG / 100 ML
HISTIDINE
93 MG / 100 ML
FISH OIL
420 MG / 100 ML
GLYCINE
350 MG / 100 ML
LEUCINE
230 MG / 100 ML
METHIONINE
130 MG / 100 ML
MAGNESIUM SULFATE
38 MG / 100 ML
OLIVE OIL
700 MG / 100 ML
PROLINE
350 MG / 100 ML
POTASSIUM CHLORIDE
140 MG / 100 ML
PHENYLALANINE
160 MG / 100 ML
SERINE
210 MG / 100 ML
SODIUM ACETATE TRIHYDRATE
110 MG / 100 ML
SODIUM GLYCEROPHOSPHATE
130 MG / 100 ML
SOYBEAN OIL
850 MG / 100 ML
TAURINE
32 MG / 100 ML
TRYPTOPHAN
63 MG / 100 ML
THREONINE
140 MG / 100 ML
TYROSINE
12 MG / 100 ML
VALINE
200 MG / 100 ML
ZINC SULFATE HEPTAHYDRATE
0.4 MG / 100 ML
LYSINE (LYSINE ACETATE)
210 MG / 100 ML
MEDIUM CHAIN TRIGLYCERIDES (MCT)
850 MG / 100 ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
7d26e7e64657e362
Type
Standard
Back to Health Canada Approvals